Your browser doesn't support javascript.
loading
Brain 11 C-ITMM PET to longitudinally assess type 1 metabotropic glutamate receptor availability in Alzheimer's disease.
Ishibashi, Kenji; Miura, Yoshiharu; Wagatsuma, Kei; Kameyama, Masashi; Ishii, Kenji.
Affiliation
  • Ishibashi K; Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
  • Miura Y; Department of Neurology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Wagatsuma K; Department of Neurology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Kameyama M; Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
  • Ishii K; Department of Diagnostic Radiology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
J Neuroimaging ; 31(5): 864-868, 2021 09.
Article in En | MEDLINE | ID: mdl-34143915
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Metabotropic Glutamate / Alzheimer Disease Limits: Humans Language: En Journal: J Neuroimaging Journal subject: DIAGNOSTICO POR IMAGEM / NEUROLOGIA Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Metabotropic Glutamate / Alzheimer Disease Limits: Humans Language: En Journal: J Neuroimaging Journal subject: DIAGNOSTICO POR IMAGEM / NEUROLOGIA Year: 2021 Type: Article Affiliation country: Japan